Inventor · disambiguated record
Ingo Flamme
Also filed as: FLAMME INGO
24 granted patents·9 pending applications·82 citations·filing 2003–2023
94Inventor score
Top patents by PatentIndex Score
33 records- 0187US8389520B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesTHEDE KAI·Filed 2007·Granted Mar 5, 2013·8 cites·10 claims
- 0287US8067407B2Substituted dihydropyrazolones and their useJESKE MARIO·Filed 2009·Granted Nov 29, 2011·10 cites·21 claims
- 0386US8399471B2Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the sameFIGUEROA PEREZ SANTIAGO·Filed 2007·Granted Mar 19, 2013·18 cites·6 claims
- 0485US8653111B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesTHEDE KAI·Filed 2012·Granted Feb 18, 2014·7 cites·14 claims
- 0583US8084481B2Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsMEIER HEINRICH·Filed 2007·Granted Dec 27, 2011·11 cites·11 claims
- 0681US8524699B2Substituted dihydropyrazolones and use thereof as HIF-prolyl-4-hydroxylase inhibitorsTHEDE KAI·Filed 2007·Granted Sep 3, 2013·6 cites·10 claims
- 0781US8252817B2Dipyridyl-dihydropyrazolones and their useFLAMME INGO·Filed 2006·Granted Aug 28, 2012·7 cites·10 claims
- 0878US8609698B2Substituted dipyridyl-dihydropyrazolones and use thereofTHEDE KAI·Filed 2007·Granted Dec 17, 2013·4 cites·14 claims
- 0977US8580778B2Substituted dihydropyrazolones and their useJESKE MARIO·Filed 2011·Granted Nov 12, 2013·3 cites·36 claims
- 1075US12173068B2Anti-sema3a antibodies and uses thereofBAYER AG·Filed 2023·Granted Dec 24, 2024·0 cites·9 claims
- 1173US7989633B24-Chromenonyl-1,4-dihydropyridines and their useBAYER SCHERING PHARMA AG·Filed 2006·Granted Aug 2, 2011·2 cites·6 claims
- 1272US9168249B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2015·Granted Oct 27, 2015·1 cites·2 claims
- 1372US8987261B2Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2013·Granted Mar 24, 2015·1 cites·7 claims
- 1471US12503491B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2023·Granted Dec 23, 2025·0 cites·8 claims
- 1569US8058447B24-Chromenonyl-1,4-dihydropyridinecarbonitriles and the use thereofKUHL ALEXANDER·Filed 2006·Granted Nov 15, 2011·2 cites·7 claims
- 1668US9315543B2Tyrosine based linkers for the releasable connection of peptidesBAYER IP GMBH·Filed 2012·Granted Apr 19, 2016·1 cites·6 claims
- 1767US9085572B24-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseasesFLAMME INGO·Filed 2012·Granted Jul 21, 2015·1 cites·6 claims
- 1862US12384843B2Anti-semaphorin 3A antibodiesBAYER AG·Filed 2022·Granted Aug 12, 2025·0 cites·11 claims
- 1962US11667675B2MASP inhibitory compounds and uses thereofBAYER AG·Filed 2020·Granted Jun 6, 2023·0 cites·3 claims
- 2062US10035818B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBayer Pharma AG·Filed 2017·Granted Jul 31, 2018·0 cites·3 claims
- 2158US9603936B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBAYER IP GMBH·Filed 2012·Granted Mar 28, 2017·0 cites·9 claims
- 2256US2014038938A1Substituted dihydropyrazolones and their useBAYER IP GMBH·Filed 2013·Application pending·0 cites
- 2354US2016229858A1Substituted dihydropyrazolones for treating cardiovascular and hematological diseasesBAYER IP GMBH·Filed 2015·Application pending·0 cites
- 2453US9649363B2Polyethylene glycol based prodrug of adrenomedullin and use thereofBAYER IP GMBH·Filed 2015·Granted May 16, 2017·0 cites·9 claims
- 2552US2024010684A1Masp inhibitory compounds and uses thereofBAYER AG·Filed 2021·Application pending·0 cites
- 2651US2007117142A1Regulation of novel human asparagine-hydroxylasesBAYER HEALTHCARE AG·Filed 2006·Application pending·0 cites
- 2750US8859601B2Substituted benzyl and phenylsulfonyl triazolones, and use thereofBRÜGGEMEIER ULF·Filed 2009·Granted Oct 14, 2014·0 cites·7 claims
- 2850US2006110769A1Regulation of novel human prolyl 4-hydroxylasesBAYER AG·Filed 2005·Application pending·0 cites
- 2946US2013005704A1Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptorsBAYER PHARMA AKTIENGESELLSHAFT·Filed 2011·Application pending·0 cites
- 3046US2006040265A1Regulation of novel human asparagine-hydroxylasesBAYER HEALTHCARE AG·Filed 2003·Application pending·0 cites
- 3144US8404709B2Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereofFIGUEROA PEREZ SANTIAGO·Filed 2007·Granted Mar 26, 2013·0 cites·5 claims
- 3243US2022387608A1Adrenomedullin-analogues for long-term stabilization and their useBAYER AG·Filed 2020·Application pending·0 cites
- 3332US2018022780A1Stabilization adrenomedullin derivatives and use thereofBayer Pharma AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ingo Flamme files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →